Increased level of oxidized LDL-dependent monocytederived microparticles in acute coronary syndrome

Noriko Matsumoto; Shosaku Nomura; Hiroshi Kamihata; Yutaka Kimura; Toshiji Iwasaka

doi:10.1160/TH03-04-0247

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2004; 91(01): 146-154
DOI: 10.1160/TH03-04-0247

Cell Signalling and Vessel Remodelling

Schattauer GmbH

Increased level of oxidized LDL-dependent monocytederived microparticles in acute coronary syndrome

Authors

Noriko Matsumoto

¹Second Department of Internal Medicine, Kansai Medical University, Osaka Japan
Shosaku Nomura

²First Department of Internal Medicine, Kansai Medical University, Osaka Japan
Hiroshi Kamihata

¹Second Department of Internal Medicine, Kansai Medical University, Osaka Japan
Yutaka Kimura

¹Second Department of Internal Medicine, Kansai Medical University, Osaka Japan
Toshiji Iwasaka

¹Second Department of Internal Medicine, Kansai Medical University, Osaka Japan

Abstract

Summary

We measured and compared the levels of plasma soluble (s) Pselectin, sCD40L, platelet-derived microparticles (PDMP), monocyte-derived microparticles (MDMP), and anti-oxidized LDL antibody, to obtain a better understanding of their potential contribution to vascular complications in acute coronary syndrome (ACS). The concentrations of sP-selectin, sCD40L, PDMP, and MDMP in ACS patients were significantly higher than those in normal controls and patients with stable angina.When levels of these markers were compared with differences in concentration of anti-oxidized LDL antibody, all markers were significantly higher in ACS patients with a high level of antioxidized LDL antibody. Next, a monocytic cell line (THP-1) was incubated with high shear stress-induced platelet aggregates and PDMP. After incubation,THP-1 cells generated tissue factorexpressing MDMPs. This finding was particularly significant in the presence of oxidized LDL. These findings suggest that elevated levels of MDMPs may be a sign of atherosclerotic development in ACS patients, particularly those who exhibit anti-oxidized LDL antibodies.

Keywords

Monocyte-derived microparticle - P-selectin - acute coronary syndrome - tissue factor - anti-oxidized LDL antibody

Full Text

References

References
1 Fuster V, Badimon L, Badimon JJ. et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-50.
2 Gawaz M, Neuwmann FJ, Ott I. et al. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation 1996; 93: 229-37.
3 Mallat Z, Benamer H, Hugel B. et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841-3.
4 Philippou H, Adami A, Amersey RA. et al. A novel specific immunoassay for plasma twochain factor VIIa: investigation of FVIIa levels in normal individuals and in patients with acute coronary syndromes. Blood 1997; 89: 767-75.
5 Toschi V, Gallo G, Lettino M. et al. Tissue factor modulates thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594-9.
6 Ardissino D, Merlini PA, Ariens R. et al. Tissue-factor antigen and activity in human coronary atherosclerotic plaques. Lancet 1997; 349: 769-71.
7 Neumann FJ, Ott I, Marx N. et al. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 1997; 17: 3399-405.
8 Sarma J, Laan CA, Alam S. et al. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002; 105: 2166-71.
9 Furman MI, Barnard MR, Krueger LA. et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001; 38: 1002-6.
10 Satta N, Toti F, Feugeas O. et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 1994; 153: 3245-55.
11 Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol 1989; 161: 4382-7.
12 Robinson RA, Worfolk L, Tracy PB. Endotoxin enhances the expression of monocyte prothrombinase activity. Blood 1992; 79: 406-11.
13 Diamant M, Nieuwland R, Pablo RF. et al. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002; 106: 2442-7.
14 Chobanian AV. Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia co-exist. Hypertension 1991; 18: 130-1.
15 Croft KD, Beilin LJ, Vandongen R. et al. Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia. Atherosclerosis 1990; 83: 101-9.
16 Fogelman AM, Shechter I, Seager J. et al. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in macrophages. Proc Natl Acad Sci USA 1980; 77: 2214-8.
17 Puurunen M, Manttari M, Manninen V. et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med 1994; 154: 2605-9.
18 Erkkila AT, Narvanen O, Lehto S. et al. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2000; 20: 204-9.
19 Nomura S, Suzuki M, Katsura K. et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995; 116: 235-40.
20 Miyazaki Y, Nomura S, Miyake T. et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996; 88: 3456-64.
21 Nomura S, Nakamura T, Cone J. et al. Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation. Cytometry 2000; 40: 173-81.
22 Miyake T, Nomura S, Komiyama Y. et al. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation. Thromb Haemost 1997; 78: 902-9.
23 Omoto S, Nomura S, Shouzu A. et al. Detection of monocyte-derived microparticles in patients with type 2 diabetes mellitus. Diabetologia 2002; 45: 550-5.
24 Dachary-Prigent J, Freyssinet JM, Pasquet JM. et al. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 1993; 81: 2554-65.
25 Heeschen C, Dimmeler S, Hamm CW. et al. CAPTURE Study Investigators Soluble CD40 ligand in acute coronary syndrome. N Engl J Med 2003; 348: 1104-11.
26 Lane P, Brocker T, Hubele S. et al. Soluble CD40 ligand can replace the normal T cell derived CD40 ligand signal to B cells in T cell-dependent activation. J Exp Med 1993; 177: 1209-13.
27 Ikeda Y, Handa M, Kawano K. et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991; 87: 1234-40.
28 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248-54.
29 Heller JI, Crowley JR, Hazen SL. et al. Phydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima. J Biol Chem 2000; 275: 9957-62.
30 Packham MA, Mustard JF. The role of platelets in the development and omplications of atherosclerosis. Semin Hematol 1986; 23: 8-19.
31 Sims PJ, Faioni EM, Wiedmer T. et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and expres prothrombinase activity. J Biol Chem 1988; 263: 1820512.
32 Nomura S, Komiyama Y, Miyake T. et al. Amyloid ?-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost 1994; 72: 519-22.
33 Nomura S, Shouzu A, Omoto S. et al. Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes. Thromb Haemost 1998; 80: 388-92.
34 Nomura S, Tandon NN, Nakamura T. et al. High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis 2001; 158: 277-87.
35 Weyrich AS, Elstad MR, McEver RP. et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996; 97: 1525-34.
36 Neumann FJ, Marx N, Gawaz M. et al. Induction of cytokine expression in leukocytes by binding of thrombin stimulated platelets. Circulation 1997; 95: 2387-94.
37 Rioufol G, Finet G, Ginon I. et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome. Circulation 2002; 106: 804-8.
38 Laszik Z, Jansen PJ, Cummings RD. et al. Pselectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood 1996; 88: 3010-21.
39 Goto S, Sakai H, Goto M. et al. Enhanced shear-induced platelet aggregation in acute myocardial infarction. Circulation 1999; 99: 608-13.
40 Sabatier F, Roux V, Anfosso F. et al. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factordependent procoagulant activity. Blood 2002; 99: 3962-70.
41 Marmur JD, Thiruvikraman SV, Fyfe BS. et al. Identification of active tissue factor in human coronary atheroma. Circulation 1996; 94: 1226-32.
42 Wada H, Kaneko T, Wakita Y. et al. Effect of lipoproteins on tissue factor activity and PAI-II antigen in human monocytes and macrophages. Int J Cardiol 1994; 47: S21-5.
43 Combes V, Simon AC, Grau GE. et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102.